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Abstract 
Macrophages, dendritic cells, and toll-like receptors (TLRs) are integral 
components of the innate immune system. This rapidly reactive system responds 
immediately to infectious or other non-self agents, thereby inducing inflammatory 
response to protect the host until the generation of slower adaptive immune system. The 
fundamentals of innate immune system, functional characteristics of TLRs, and signaling 
pathways of TLR4 are discussed for easy understanding by the readers. Studies showed 
that the growth and progression of endometriosis continue even in ovariectomized animal. 
This indicates that besides ovarian steroid hormones, the growth of endometriosis can be 
regulated by innate immune system in pelvic environment. As a component of innate 
immune system, increased infiltration of macrophages has been described in the intact 
tissue and peritoneal fluid of women with endometriosis. In this review article, we 
discussed the role of bacterial endotoxin and TLR4 in endometrium and endometriosis 
and outlined the involvement of endotoxin in causing adverse reproductive outcome. 
 
Introduction 
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 Innate (natural or constitutive) immunity in our body depends on toll-like 
receptors. From flies to mammals, these proteins provide a first line defense and are 
implicated in infectious and autoimmune diseases. While scientists have been studying 
the adaptive (acquired) immune response for several decades, the recognition of the 
importance of innate immunity was established only during the past few years to 
understand the association between adaptive and innate immune system. Why is innate 
immunity necessary for our body? There was always a question of how adaptive immune 
system could defend us if it were alone, because adaptive immunity depends on the 
multiplication of host cells with a generation time of at least 12 hours, whereas microbes 
can divide every 20 minutes. To cover this lag, the rapidly reactive innate immune system 
responds immediately to infectious agents, protecting the host until slower adaptive 
system kicks in and eventually makes memory cells for long-term response  [1, 2]. 
Therefore, innate immune responses are, in many cases, necessary for triggering an 
adaptive immune response just as adjuvant is necessary for a significant vaccine 
response.  
 Functional characterization of Toll-like receptors (TLRs) has established that 
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innate immunity is a skillful system that detects invasion of microbial pathogens. 
Recognition of microbial components by TLRs initiates signal transduction pathways, 
and triggers expression of genes. These genes control innate immune responses and 
further instruct development of antigen-specific adaptive immunity. In adaptive immunity, 
B and T lymphocytes utilize antigen receptors such as receptor for immunoglobulins and 
T cell receptors to recognize non-self such as foreign antigens. However, these receptors 
are present only in vertebrates. In contrast, innate immune system operates in both 
vertebrates and non-vertebrates. Mammalian innate immune cells such as macrophages 
and dendritic cells can be activated by microbial components (non-self) such as 
endotoxin or lipopolysaccharide (LPS) from Gram-negative bacteria. However, a 
receptor responsible for the recognition of LPS remained unknown until the end of 20th 
century [3].    
 Analysis of the female reproductive tract indicates that the key cells of the 
innate and adaptive immune systems are present and functionally responsive to antigens 
[4]. The innate immune system has evolved to recognize foreign structures that are not 
normally found in the host. It relies on conserved germ-line-encoded receptors that 
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recognize conserved pathogen-associated molecular patterns (PAMP) found in groups of 
microorganism [5]. The pattern recognition receptors (PRR) of the host that recognize 
PAMP in female reproductive tract are expressed on the cells of the innate immune 
system. Toll-like receptors are one group of PRRs that are expressed on macrophages (M
φ), dendritic cells, and as more recently shown, on neutrophils, natural killer cells, and 
on epithelial cells [4-6].  
At the end of the 20th century, Toll was shown to be an essential receptor for 
host defense against fungal infection in Drosophila (fly), which has only innate immunity 
[7]. One year later, a mammalian homolog of the Toll receptor (now termed TLR4) was 
shown to induce expression of genes involved in inflammatory responses [8]. In addition, 
a point mutation in the Tlr4 gene has been identified in a mouse strain that is unresponsive 
to LPS [9]. These studies have made rapid progress in our understanding that innate 
immune system senses invasion of microbial pathogens by TLRs. Furthermore, 
activation of the innate immunity is a critical step to the development of antigen-specific 
acquired immunity.  
Now it is well recognized that innate and adaptive immune system are the two 
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key branches that determine host protection throughout the female reproductive tract and 
at other mucosal surfaces, including the respiratory, gastrointestinal and urinary tracts. 
Our understanding of the innate immune system is a result, in large part, of the pioneering 
studies of Charles Janeway, who demonstrated that innate immunity covers many areas of 
host defense against pathogenic microbes [10]. During the last decade, investigations of 
the innate immune system have shown that microbial pathogens are recognized by TLRs 
that, in turn, regulate the activation of both innate and adaptive immunity [11].  
(1) Identification of the TLR Family: 
 After the characterization of the first mammalian TLR (TLR4), several proteins 
that are structurally related to TLR4 were identified and named Toll-like receptors [12]. 
Mammalian TLRs comprise a large family consisting of at least 11 members. TLRs1-9 
were found to be conserved between human and mouse. TLR10 is presumably functional 
in the human but non-functional in mouse. Similarly, mouse TLR11 is functional, but 
there is a stop codon in the human TLR11 gene, which results in a lack of production of 
human TLR11 [13].   
 The cytoplasmic portion of TLRs shows high similarity to that of the 
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interleukin (IL)-1 receptor family, and is termed a Toll/IL-1 receptor (TIR) domain. 
Despite this similarity, the extracellular portions of both types of receptors are structurally 
unrelated. The IL-1 receptors possess an immunoglobulin-like domain, whereas TLRs 
bear leucin-rich repeats (LRRs) in the extracellular domain. Functionally, a critical role of 
TLR4 in the recognition of microbial component was initially characterized [9]. 
Subsequently, it has been established that individual TLRs play important roles in 
recognizing specific microbial components derived from pathogens including bacteria, 
fungi, protozoa and viruses (Figure 1).  
 Toll-like receptor 2 (TLR2) is essential in the recognition of microbial 
lipopeptides and peptidoglycan derived from Gram-positive bacteria. TLR1 and TLR6 
cooperate with TLR2 to discriminate subtle differences between triacyl and diacyl 
lipopeptides, respectively. TLR2 forms heterophilic dimers with TLR1 and TLR6, both 
of which are structurally related to TLR2 [14]. TLR4 is the receptor for LPS derived from 
the outer membrane of Gram-negative bacteria. TLR5 recognizes flagellin. TLR3 is 
implicated in the recognition of viral dsRNA associated with viral replication, whereas 
TLR7 and TLR8 are implicated in viral-derived ssRNA recognition. Thus, 
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polyriboinosinic:polyribocytidylic acid [poly (I:C)], which is a synthetic mimetic for 
dsRNA, can induce TLR3 signaling [15]. TLR9 is essential in unmethylated (CpG) DNA 
recognition [3]. As shown in Figure 1, the TLR family members recognize specific 
patterns of microbial components. TLR1, TLR2, TLR4, TLR5 and TLR6 are expressed 
on cell surfaces and recognize microbial components in different body fluids. In contrast, 
TLR3, TLR7, TLR8 and TLR9 are present in endosomes within the cytoplasm [16, 17].  
(2) Ligands of Toll-like Receptor 4 (TLR4): 
 There are two types of ligands, exogenous and endogenous, for TLR4 [18].  As 
described above, TLR4 is an essential receptor for bacterial endotoxin or LPS recognition. 
In addition to LPS, other exogenous ligands are F protein from respiratory syncytial virus, 
chlamydial heat shock protein 60 and taxol, a plant derived anticancer reagent that 
mimics the action of LPS in mice but not in humans. Endogenous ligands of TLR4 
comprise fibronogen, fibronectin, heparan sulphate, hyaluronic acid and heat shock 
proteins (Hsp) 60 and 70. However, all of these endogenous ligands require very high 
concentration to activate TLR4. It has been shown that contamination of LPS in Hsp70 
preparation confers ability to activate TLR4. LPS is a very potent immuno-activator and 
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accordingly, TLR4 can be activated by a very small amount of LPS, contaminating these 
endogenous ligand preparations [3, 17-20]. Therefore, we need careful attention in 
biological research using these endogenous ligands. The different TLRs and their 
corresponding ligands are described in Table 1.      
(3) Signaling Pathways Triggered by TLR4 (Figure 2):   
 Several lines of evidence indicate that all TLR signaling pathways are similar 
and elicit similar biological responses except TLR3 [21, 22]. Lipopolysaccharide (LPS) is 
a potent activator of Mφ and other dendritic cells. After being released into the blood 
stream or other body fluids, LPS is immediately captured by LPS-binding protein that 
delivers LPS to TLR4 or CD14. CD14 lacks a trans-membrane domain and so is 
incapable of transducing signals [16]. Both the positional cloning of the locus responsible 
for LPS hypo-responsiveness in C3H/HeJ mice and the generation of TLR4 knockout 
mice have shown that TLR4 is essential for LPS signaling [9, 19]. In addition, the 
interaction of LPS with TLR4 requires another molecule, MD-2, which associates with 
the extracellular domain of TLR4. MD-2 is also involved in the intracellular transport of 
TLR4 and subsequent activation of a number of intracellular adaptor molecules [23].   
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 Once TLRs are activated, the intracellular signaling pathways are very similar 
between insects and mammals. In mammals, TLR4 signaling involves activation of one 
or more of the adaptor proteins. The adaptors relevant to TLR4 signaling are known as 
MyD88 (myeloid differentiation factor 88), TIRAP (TIR domain-containing adaptor 
protein), TRIF (TIR-domain containing-adaptor inducing IFN- β ), and TRAM 
(TRIF-related adaptor molecule) [1, 3]. Most TLRs act through MyD88 alone or through 
both MyD88 and TIRAP, which leads to the production of different pro-inflammatory 
cytokines. MyD88 is an adaptor molecule that recruits the kinase IRAK (IL-1 
receptor-associated kinase) to the TLR4 receptor complexes after stimulation with LPS. 
The lipopeptide activation of nuclear factor (NF)-κB and MAP (mitogen-activated 
protein) kinases, as mediated by TLR2, is completely abolished in TLR2-depleted or 
MyD88-deficient Mφ. By contract, LPS activation of MAP kinases and NF-κB remains 
intact in MyD88-deficient Mφ. This indicates that LPS response is mediated by both 
MyD88-dependent and MyD88-independent pathways, each of which leads to the 
activation of MAP kinases and NF-κB (Figure 2).   
The MyD88-dependent pathway is essential, however, for the inflammatory 
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response mediated by LPS. The TIRAP has a crucial role in the MyD88-dependent 
signaling pathway shared by TLR2 and TLR4. Recent studies have shown that 
MyD88-independent pathway for TLR4 operates through different adaptor molecules, 
TRIF and TRAM, activates interferon (IFN) regulatory factor 3 (IRF-3), up-regulates 
co-stimulatory molecules and leads to the subsequent induction of type I interferon such 
as IFN-β, nitric oxide synthase (iNOS) and IFN-inducible protein (IP-10) [1,3]. It is 
important to remember that in addition to activation of IRF3, MyD88-independent 
pathway also elicits delayed activation of NF-κB. Studies are still limited with 
MyD88-independent pathway. TLR4 signaling pathways are shown in Figure 2.  
 Unlike other TLRs, TLR3 uses only one adaptor protein, TRIF, whose 
activation leads to IRF3 translocation to the nucleus. IRF3 dimerizes and enters the 
nucleus where it binds to interferon-sensitive response element (ISRE) motifs and 
induces the expression of type I interferons, IFN-α and IFN-β [21, 22]. Female 
reproductive tract and placenta may become exposed to viruses in addition to bacterial or 
fungal infection, which may pose a substantial threat to reproductive outcome or 
embryo/fetus well-being. Although studies are limited, it is important to determine the 
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type of virus and whether the engagement of TLR3 with viral dsRNA could induce 
production of factors necessary to generate an antiviral response. In fact, TLR3 
expression has been demonstrated in the epithelial cells of vagina, uterine cervix, 
endometrium, fallopian tubes and also in placenta [24, 25].   
(4) Links between Innate and Adaptive Immune System (Figure 3):    
 The TRIF/TRAM pathway provides a direct link between TLR4 activation and 
adaptive (acquired) immunity. Although purified LPS acts like a strong adjuvant, its 
effects are abolished in the mutant mouse strains. This suggests that both inflammatory 
and adjuvant effects of LPS flow through TLR4. Combination of MyD88/TIRAP and 
TRIF/TRAM pathways provides a biochemical basis for how adjuvants work. Activation 
of adaptive immune system requires antigen-presenting cells such as macrophages and 
dendritic cells to express co-stimulatory molecules such as CD40, CD80 and CD86, and 
to produce pro-inflammatory cytokines. When TLR4 recognizes LPS on the surface of 
macrophages or dendritic cells, it leads to the production of cytokines via MyD88/TIRAP 
pathway and co-stimulatory molecules via TRIF/TRAM pathway, providing both 
components to activate T helper lymphocytes of the adaptive immune system [1, 3].   
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 Some evidence suggests that the initial innate immune process influences the 
type of acquired immune response that is generated [1, 14]. When naïve T helper cells are 
presented with antigens by antigen-presenting cells, they differentiate into two subsets, T 
helper 1 (Th1) and T helper 2 (Th2) cells. Th1 cells secrete interferon-γ, which promote  
mainly cellular immunity whereas Th2 cells produce IL-4, IL-5, IL-10, and IL-13, and 
promote mainly humoral immunity [1, 14]. It has been demonstrated that autoimmune 
diseases such as Crohn’s disease and multiple sclerosis are associated with an abnormally 
strong Th1 response, whereas allergic diseases seem to involve an abnormally strong Th2 
response.   
 Which limb of acquired immunity predominates may be modulated by innate 
immune response. For instance, MyD88-deficient mice are skewed toward a Th2 
response and activation of TLR4 by LPS stimulates Th1 activity. This suggests that the 
default pathway for acquired immune development with absent MyD88 signaling is the 
Th2 pathway. This integrated knowledge of innate and adaptive immunity may give 
future therapeutic possibilities for infectious diseases, allergic diseases and autoimmune 
diseases.  
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(5) Bacterial Endotoxin and TLR4 in Endometrium:  
 For most of the reproductive cycle in humans and animals, the uterus is thought 
to be sterile or at least clear of pathogenic bacteria, but it is readily contaminated with 
bacteria during sexual intercourse and around the time of parturition. In fact, the upper 
genital tract is vulnerable to the spread of microorganisms from the lower genital tract, 
resulting in the development of infectious diseases such as endometritis and salpingitis. 
These diseases, commonly termed as pelvic inflammatory disease, deteriorate women’s 
health, posing risks of infertility and ectopic pregnancy. In addition, these infections 
perturb normal ovarian cycles by suppressing follicular growth and disrupting luteolysis 
as exemplified in the cattle [26]. In fact, an enormous number of Gram-negative and 
Gram-positive microbes are present in vaginal cavity (Table 2). All these microbes reside 
in vaginal cavity as normal vaginal flora and may cause genitourinary infections upon 
ascending migration [27].  
In recent years increasing attention has been paid to innate immunity, the 
primary defense system against pathogens. Escherichia coli (E.coli) are the most 
commonly isolated pathogenic bacteria from clinical uterine diseases in cattle [26] and 
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also in human vaginal cavity [27]. The ascending migration of E.coli towards endometrial 
cavity is possible that may cause contamination of endometrium. In bovine uterine lumen, 
there are high concentrations of the pathogenic ligand of E.coli known as bacterial 
endotoxin or LPS. The endometrium provides a barrier against infection and an 
opportunity to detect these bacteria by innate immune receptors.  Toll-like receptors were 
first identified on immune cells but have since been identified on other cell types 
including endometrium [28]. In the human endometrium, nine TLRs are identified at the 
protein and mRNA level including TLR4 [29-32]. Engagement of these receptors initiates 
a signaling cascade stimulating the production of immune mediators that orchestrate the 
immune response to clear the infection. It is the principal role of TLR4 to detect LPS, 
although signaling through TLR4 also requires accessory molecules such as LBP, CD14 
and MD2.  
 As a component of innate immune system, an increase in the infiltration of M
φ was found in normal endometrium and also in the endometrium of women with 
different reproductive diseases such as endometriosis, adenomyosis and uterine 
leiomyoma [33-35]. The expression of TLR4 mRNA and protein was detected in Mφ, 
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endometrial epithelial cells and stromal cells [29, 30, 36]. RT-PCR analysis also 
demonstrated the expression of CD14, MD2 and MyD88 mRNA in both endometrial 
epithelial cells (EECs) and endometrial stromal cells (ESCs) [30]. The expression levels 
of TLR4, CD14, and MD2 appeared to be higher in ESCs compared with that in EECs. 
However, the expression levels of MyD88 were similar between ESCs and EECs. 
Treatment of endometrial stromal cells with LPS significantly increased the 
production of hepatocyte growth factor (HGF), vascular endothelial cell growth factor 
(VEGF), interleukin (IL)-6, IL-8 and tumor necrosis factor alpha (TNFα ) in a 
dose-dependent fashion [30, 37, 38]. A significantly more growth promoting effect of 
LPS was observed on endometrial cells derived from women with endometriosis when 
compared with similar cells derived from control women [37, 38]. The stimulatory effect 
of LPS was inhibited by the addition of neutralizing antibodies for TLR4 and also by an 
LPS antagonist, polymyxin B [39]. This indicates that Mφ, ESCs and EECs express 
TLR4 and respond to LPS through TLR4. In fact, we recently demonstrated that both 
ESCs and EECs were able to significantly proliferate in response to LPS and this growth 
promoting effect of LPS was abrogated after pretreatment of cells with anti-TLR4 
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antibody (40, 41). Since, there are other exogenous and endogenous ligands for TLR4 in 
addition to LPS, we presume that blocking of TLR4 alone is more effective in order to 
suppress inflammatory response in pelvic environment and cell growth.  
A recent study [30] demonstrated that LPS was able to stimulate TLR4- and 
CD14-mediated increased production IL-8 by ESCs. This effect of LPS was associated 
with the activation of NF-κB as examined by nuclear translocation of NF-κB in ESCs. 
On the other hand, LPS alone did not stimulate IL-8 secretion in EECs. However, LPS did 
stimulate IL-8 secretion from EECs in the presence of soluble CD14. These findings 
indicate that TLR4 system might represent local immunity in the human endometrium 
with different modes of TLR4 actions between ESCs and EECs. The role of soluble CD14 
in LPS-stimulated proliferation of ESCs and EECs is yet to be determined.  
Human endometrium is regulated by changing concentration of female sex 
hormones, estradiol (E2) and progesterone (P), during the ovarian cycle [42]. These 
ovarian steroids also have a profound effect on infections. For example, in humans, 
rodents and cattle, P suppresses uterine immune function by decreasing the proliferative 
capacity of lymphocytes, thereby increasing the susceptibility to bacterial infection [42, 
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43]. Conversely, E2 may play a role in the recruitment of immune cells as more Mφ 
infiltrate in the endometrium when E2 concentrations are higher in rodents [42, 43].  
In addition to producing different macromolecules as mentioned above, 
endometrial explants also produce prostaglandins in response to LPS, with an increasing 
ratio of PGE2 to PGF2α [43]. A recent report by Herath et al. [43] demonstrated that 
addition of LPS or E.coli to bovine endometrial stromal and epithelial cells stimulated 
production of PGE2 and PGF2 α  with a parallel increase in the expression of 
cyclooxygenase (COX) 2 mRNA. Polymyxin B, an LPS antagonist, was able to abrogate 
the production of prostaglandins. In addition, E2 and P were found to inhibit 
LPS-mediated production of PGE2 and PGF2α, indicating a role of steroid hormones in 
bacterial infections. TLR4 mRNA, CD14 mRNA and proteins were also detected in 
bovine endometrial cells. This study indicates that endometrial cells detect and respond to 
bacteria, which modulate their endocrine function.    
(6) Bacterial Endotoxin and TLR4 in Endometriosis: 
 Endometriosis, the presence of functional endometrium outside of the uterine 
cavity, is a common disease, causing abdominal pain, dysmenorrhea, dyspareunia and 
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infertility in 6-10% of the female population. The pathogenesis of endometriosis is still 
controversial. A number of papers have already demonstrated the potential role of ovarian 
steroid hormones in the growth of endometriosis. However, as a non-self lesion in the 
pelvic environment, the growth or persistence of endometriosis can also be regulated by 
the innate immune system. We already came to learn that an innate immune system and 
ovarian steroid hormones participate either alone or in an orchestrated fashion in the 
regulation of endometriosis. In fact, as a cell component of innate immune system, 
increased infiltration of Mφ has been demonstrated in the blood-filled opaque red 
endometriotic lesions, their corresponding eutopic endometria and also in the peritoneal 
fluid [33, 44].  
 The different macromolecules as secreted by Mφ in the pelvic environment 
are believed to enhance the growth of endometriosis. However, the initial inflammatory 
mediator that stimulates Mφ for the production of different cytokines and growth factors 
was poorly described. We reported that bacterial endotoxin, lipopolysaccharide (LPS), 
could be a potential inflammatory mediator of Mφ  stimulation and consequent 
production of different cytokines and growth factors, such as HGF, VEGF, IL-6 and TNF
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α in pelvic environment [37]. This LPS and together with LPS-induced macromolecules 
are possibly involved in the growth of endometriosis in an autocrine or paracrine 
mechanism [37].  
 We recently demonstrated that activation of basal Mφ further enhanced the 
response of these cells to ovarian steroids. Exogenous treatment with E2 was able to 
further increase the amount of both HGF and VEGF secretion by peritoneal fluid Mφ
when these cells were activated with LPS [44]. These results from our laboratory 
confirmed that irrespective of activation status, CD68-immunoreactive Mφ  were 
independently stimulated to produce HGF and VEGF by estrogen. This indicates that an 
inflammatory response and ovarian steroid hormones may function either alone or in 
combination to regulate the production of different macromolecules in the pelvic 
environment. The enhanced cell proliferation in response to IL-6, TNFα, LPS, and 
estrogen suggested that a combined effect among steroid hormone, initial inflammatory 
mediator (LPS) and other secondary inflammatory mediators (IL-6, TNFα) may be 
involved in the growth of endometriosis [44, 45].  
 There was no information until now about the presence of bacterial endotoxin 
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in pelvic environment. We examined endotoxin concentration for the first time in the 
peritoneal fluid of women with or without endometriosis. We found that endotoxin 
concentration in PF was significantly higher in women with endometriosis than that in 
non-endometriosis. The expression pattern of TLR4 in Mφ, endometrial cells and 
endometriotic cells was identical between women with endometriosis and 
non-endometriosis in the proliferative phase but this expression pattern was higher in the 
secretory phase of the menstrual cycle [31, 32]. The production of HGF, VEGF, IL-6 and 
TNFα  by LPS-treated peritoneal Mφ  was significantly higher in women with 
endometriosis than that in women without endometriosis. This was evident at both 
protein and mRNA level. The blocking of TLR4 after pretreatment of Mφ  with 
anti-TLR4 antibody significantly reduced the production of all these cytokines [39-41]. 
The addition of culture media from TLR4-blocked macrophages caused significant 
suppression in the growth of endometrial and endometriotic cells comparing to TLR4 
non-blocking macrophages. The direct application of LPS also promoted the growth of 
endometrial cells and was suppressed after pretreatment of cells with anti-TLR4 antibody 
[39-41].  
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These results suggested that a substantial amount of endotoxin in PF is 
involved in pelvic inflammation and may promote TLR4-mediated growth of 
endometriosis. Therefore, targeting TLR4 could be a new therapeutic strategy to reduce 
inflammatory reaction in pelvic environment and prevent consequent growth of 
endometriosis. We recently reported that an internal stress reaction and an inflammatory 
reaction in peritoneal cavity cooperate with each other and are involved in 
TLR4-mediated growth of endometriosis [39].  
 The higher concentration of bacterial endotoxin in the pelvic environment 
added further evidence that endometriosis induces an inflammatory reaction. But we 
don’t know the exact source of this endotoxin in pelvic environment. There might be two 
mechanisms for the residual accumulation of bacterial endotoxin in pelvic environment: 
(a) translocation of E.coli or endotoxin from the gut through enterocytes and their entry 
into the pelvic cavity as demonstrated by Alexander et al. [46], (b) contamination of 
menstrual blood by E.coli after ascending migration from vagina.  
Since endometriosis is a product of retrograde menstruation and LPS is a cell 
wall extract of E.coli, we speculated that menstrual blood of women with endometriosis 
Review Article by Khan, Page 23  
could be contaminated with E.coli.  We collected menstrual blood with strict aseptic 
measure on day 1 to day 3 of menstrual cycle from women with and without 
endometriosis. We cultured menstrual blood on eosin methylene blue (EMB) agar plate 
and examined the colony formation of E.coli. We detected colony formation of E.coli in 
menstrual blood and this was significantly higher in women with endometriosis than that 
in non-endometriosis [40, 41, 47]. The contamination of menstrual blood with E.coli was 
associated with a parallel increase in the level of endotoxin in the menstrual blood. The 
level of endotoxin in menstrual blood was significantly higher in women with 
endometriosis than that of women with non-endometriosis [41,47]. Our findings 
suggested that contamination of menstrual blood with E.coli in women with 
endometriosis could be a constant source of bacterial endotoxin in peritoneal fluid due to 
periodic retrograde menstrual reflux and this cyclic event may initiate TLR4-mediated 
growth of endometriosis.   
(7) Endotoxin-mediated Reproductive Dysfunction and Infertility (Figure 4): 
 The ultimate fates of women who suffer from endometriosis are impairment in 
quality of life and reduction in the rate of fertilization, implantation and finally failure to 
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achieve pregnancy [48, 49]. The purpose of current medical and surgical therapy for the 
women with endometriosis is to remove endometriotic lesions, to relieve periodic or 
non-periodic pain experience and to establish pregnancy. Endometriosis-associated pain 
can be successfully alleviated either transiently or permanently by the application of 
recent therapeutic modalities. However, the problem of infertility still remains a major 
issue to be resolved. Endometriosis-associated infertility can be explained by one of the 
several mechanisms as shown in Figure 4. 
A strong inflammatory reaction of the endometrial bed elicited by the 
infiltration of inflammatory cells especially Mφ  constitutes the central feature of 
impaired fertility of affected women. These scavenger cells may have two-fold effects. 
One, direct phagocytosis of implanting embryos; secondly, indirect impairment in the 
process of implanted blastocyst. These hazardous effects of Mφ can be contributed by 
producing some biological mediators such as reactive oxygen species (ROS) or by 
inducing humoral immune response [49-51]. A moderate to severe inflammatory reaction 
in pelvic environment leads to the formation of tubo-ovarian adhesion or peri-tubal 
adhesion finally resulting in narrowing or occlusion of the Fallopian tube [52]. On the 
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other hand, endotoxin derived from Gram-negative bacteria may directly cause 
endometrial or tubal damage. Endotoxins have been found to be deleterious on 
pre-implantation stage embryos [53]. The presence of endotoxin in IVF culture media 
results in high rate of polyspermy, decreased embryo cleavage rate and blastocyst 
formation in human and bovine species. Endotoxins also possess the capacity to induce 
apoptosis of cells impairing sperm motility and induce spermicidal activity [50-53]. A 
recent ART clinical trial has demonstrated that pregnancy rate after IVF-ET was 
significantly higher in women with an endotoxin level of <200 pg/ml in menstrual fluid, 
than that in women with an endotoxin level of >200 pg/ml [54].  
Many of the biological effects of bacterial endotoxin are mediated by 
pro-inflammatory cytokines such as IL-1, IL-6, and TNF α . One recent study 
demonstrated that adding recombinant IL-6 to culture media suppressed the rate of 
blastocyst formation in mouse embryos and reduced the percentage of motile human 
spermatozoa [55]. Higher concentrations of TNF α  possess apoptosis- and 
necrosis-inducing activity on a variable type of cells including sperm, ova and 
endometrial cells [53, 56]. T-helper 2 (Th2) type cytokines (IL-4, IL-5, IL-10, IL-13) are 
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also produced at the tissue level in response to endotoxin [50, 53]. These Th2 cytokines in 
turn could induce an autoimmune response resulting in limitation of fertilization or 
implantation [26, 53]. Several of these cytokines have been implicated in the delicate 
balance of immune system that exists within the maternal-fetal interface. Any disturbance 
of this delicate immune balance within the maternal-fetal interface may result in 
pregnancy loss or other perinatal complications.  
Endotoxin also produces higher levels of prostaglandin (PG) F2α and PGE2 
by Mφ and endometrial cells. PGE2 causes immunosuppression and may promote 
growth of endometriotic cells either indirectly or directly by stimulating local aromatase 
activity resulting in the elevation of estrogen synthesis at the tissue level of endometriotic 
lesions [57, 58]. The higher local estrogen levels may recruit immune cells and induce 
inflammatory reaction in pelvic cavity and culminate in the impairment of reproductive 
outcome. PGF2α  causes uterine contraction as well as vasoconstriction, leads to 
ischemic or hypoxic change in endometrial bed and may result in abnormal sperm 
motility or implantation failure [35, 59].  
Macrophages also produce increased concentrations of ROS (OH-, O2- and 
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H2O2) in response to bacterial endotoxin. The increased generation of ROS at the tissue 
level induces a wide range of biological activity such as lipid peroxidation, protein 
denaturation, inactivation of enzymes and decomposition of cellular DNA [60]. In this 
way, ROS may cause cellular and tissue damage. These unwanted effects of ROS may 
cause impairment of ova or sperm function. Bacterial endotoxin-induced increase in ROS 
production may also cause caspase-mediated apoptosis [56]. This apoptosis-inducing 
effect of ROS may result in endometrial or tubal epithelial damage, impairment in 





 We now know that innate immunity plays an important role in the initiation of 
an immune response that follows the activation of antigen-specific adaptive immunity.  
The association between innate immunity and adaptive immunity is as important as an 
adjuvant is necessary for an effective vaccine response. A number of mechanisms are 
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involved in the development or pathogenesis of endometriosis. The production of 
pro-inflammatory cytokines and growth of endometriosis in pelvic environment can be 
regulated by innate immune system. We proposed a novel concept in the cross-talk 
between bacterial endotoxin and TLR4 in the pathogenesis of endometriosis. Targeting 
bacterial endotoxin or TLR4 could be useful as a therapeutic strategy to suppress pelvic 
inflammation and growth of endometriosis with consequent improvement in the quality 
of life and fertility rate of women who suffer from this enigmatic disease. A complete 
understanding of the mechanisms of innate immunity and its association with adaptive 
immunity will be helpful for the future development of innovative therapies for the 
manipulation of endometriosis and other reproductive diseases, infectious diseases, 
cancer and allergies.      
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Figure 1. TLRs and their ligands and is reproduced with the permission of Dr. 
Shizuo Akira of Osaka University (Int. Immunol. 17:1-14,2005). TLR2 is essential in the 
recognition of microbial lipopeptides. TLR1 and TLR6 cooperate with TLR2 to 
discriminate subtle differences between triacyl and diacyl lipopeptides, respectively. 
TLR4 is the receptor for LPS. TLR5 recognizes flagellin. TLR3 is implicated in the 
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recognition of viral dsRNA, whereas TLR7 and TLR8 are implicated in viral-derived 
ssRNA recognition. TLR9 is essential in unmethylated (CpG) DNA recognition. Thus, 
the TLR family members recognize specific pattern of microbial components.   
Figure 2. TLR4 signaling pathway and is reproduced with the permission of Dr. 
Shizuo Akira of Osaka University (Int. Immunol. 17:1-14,2005). TLR4 signaling 
pathways originate from the cytoplasmic TIR domain. A TIR domain-containing adaptor, 
MyD88, associates with the cytoplasmic TIR domain of TLR, and recruits IRAK to the 
receptor upon ligand binding. IRAK then activates TRAF 6, leading to the activation of I
κB kinase (IKK) complex. The IKK complex phosphorylates IκB, resulting in nuclear 
translocation of NF-κB which induces expression of inflammatory cytokines. TIRAP, a 
second TIR domain-containing adaptor, is involved in the MyD88-dependent signaling 
pathway via TLR2 and TLR4. In TLR3 and TLR4-mediated signaling pathways, 
activation of IRF-3 and induction of IFN-β are observed in a MyD88-independent 
manner. A third TIR domain-containing adaptor, TRIF, is essential for the 
MyD88-independent pathway. Atypical IKKs mediate activation of IRF-3 downstream of 
TRIF. A fourth TIR domain-containing adaptor, TRAM, is specific to the TLR4-mediated 
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MyD88-independent/TRIF-dependent pathway.  
Figure 3. Link between innate and adaptive immunity and is reproduced with 
the permission of Dr. Shizuo Akira of Osaka University (Int. Immunol. 17:1-14,2005). 
Innate immune cells, such as macrophages and dendritic cells, engulf pathogens by 
phagocytosis, and present pathogen-derived peptide antigens to naïve T cells. In addition, 
TLRs recognize pathogen-derived components and induce expression of genes, such as 
co-stimulatory molecules and inflammatory cytokines. Phagocytosis-mediated antigen 
presentation, together with TLR-mediated expression of co-stimulatory molecules and 
inflammatory cytokines, instruct development of antigen specific adaptive immunity, 
especially Th1 cells.  
Figure 4. Shows diagrammatic representation of different mechanisms of 
infertility in women suffering from endometriosis that may be directly or indirectly 
associated with bacterial endotoxin. LPS, lipopolysaccharide; ROS, reactive oxygen 
species. Other abbreviations as shown in this figure are described in the text.  
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